PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.10%
Revenue growth above 1.5x ON's 2.69%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
6.17%
Gross profit growth above 1.5x ON's 1.35%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
15.50%
EBIT growth above 1.5x ON's 2.36%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
15.25%
Operating income growth above 1.5x ON's 2.36%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
14.66%
Positive net income growth while ON is negative. John Neff might see a big relative performance advantage.
16.67%
Positive EPS growth while ON is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
16.92%
Positive diluted EPS growth while ON is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.40%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.52%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.30%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
71.83%
OCF growth above 1.5x ON's 26.28%. David Dodd would confirm a clear edge in underlying cash generation.
82.73%
FCF growth 50-75% of ON's 144.44%. Martin Whitman would see if structural disadvantages exist in generating free cash.
52.13%
10Y revenue/share CAGR at 50-75% of ON's 78.49%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
6.46%
5Y revenue/share CAGR under 50% of ON's 57.04%. Michael Burry would suspect a significant competitive gap or product weakness.
12.10%
3Y revenue/share CAGR under 50% of ON's 36.95%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
48.23%
10Y OCF/share CAGR at 75-90% of ON's 63.09%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
24.14%
5Y OCF/share CAGR above 1.5x ON's 8.29%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
29.91%
3Y OCF/share CAGR under 50% of ON's 1084.74%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
101.43%
Net income/share CAGR above 1.5x ON's 21.97% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
7.87%
Positive 5Y CAGR while ON is negative. John Neff might view this as a strong mid-term relative advantage.
12.80%
Below 50% of ON's 307.02%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
33.75%
Below 50% of ON's 300.14%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
16.21%
5Y equity/share CAGR at 50-75% of ON's 26.93%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
-3.10%
Negative 3Y equity/share growth while ON is at 13.30%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
2216987.49%
Dividend/share CAGR of 2216987.49% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
182.59%
Dividend/share CAGR of 182.59% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
98.80%
3Y dividend/share CAGR of 98.80% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
3.28%
AR growth well above ON's 3.27%. Michael Burry fears inflated revenue or higher default risk in the near future.
-6.05%
Inventory is declining while ON stands at 1.48%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-5.66%
Negative asset growth while ON invests at 0.89%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.92%
We have a declining book value while ON shows 0.73%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-15.40%
We’re deleveraging while ON stands at 2.14%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-1.25%
Our R&D shrinks while ON invests at 4.48%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.66%
We cut SG&A while ON invests at 1.89%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.